CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Carpal Tunnel Tissue Manipulation Device (CTMD)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02534493
NCT02534493N/ACompleted

Safety and Efficacy of a Novel Carpal Tunnel Tissue Manipulation Device in Treating Carpal Tunnel Syndrome

Pressure Profile Systems, Inc.·interventional·Posted Aug 27, 2015·Updated Dec 2, 2017

In Brief

A clinical study evaluating Carpal Tunnel Tissue Manipulation Device (CTMD) for Carpal Tunnel Syndrome. Completed, enrolled 11 participants across 1 site.

Detailed Summary

A single-center, prospective, non-randomized study to evaluate the safety and efficacy of a novel carpal tunnel tissue manipulation device in treating symptoms and decreased physical function in subjects previously diagnosed with mild to severe carpal tunnel syndrome (CTS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 27, 2015
Enrollment StartApr 1, 2015
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.8 years ago

Interventions

Carpal Tunnel Tissue Manipulation Device (CTMD)device

This piece of rigid, shaped, biocompatible plastic (polypropylene) rated for skin contact and a strong but safe hypoallergenic biocompatible medical adhesive which bonds the skin over the carpal tunnel to the plastic piece for a duration of 2-14 hours.